We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$102B
AUM Growth
+$1.43B
(+1.4%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
287
New
14
Increased
80
Reduced
134
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$518M |
| 2 |
AstraZeneca
AZN
|
+$246M |
| 3 |
Alkermes
ALKS
|
+$172M |
| 4 |
Whirlpool
WHR
|
+$94.4M |
| 5 |
Eli Lilly
LLY
|
+$78.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QGENF
QIAGEN NV
QGENF
|
+$534M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$265M |
| 3 |
Amgen
AMGN
|
+$235M |
| 4 |
NVIDIA
NVDA
|
+$233M |
| 5 |
Microsoft
MSFT
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.81% |
| 2 | Healthcare | 22.95% |
| 3 | Industrials | 16.75% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Financials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Mativ Holdings
MATV
$711M
| $8.2M | 0.01% |
180,000
| – | – |
|
227
Chubb
CB
$135B
| $7.98M | 0.01% |
60,411
| – | – |
|
|
SGI
228
Somnigroup International
SGI
$13.7B
| $7.24M | 0.01% |
+424,000
| New | +$6.33M |
|
229
Matsons
MATX
$6.18B
| $7.07M | 0.01% |
199,761
| – | – |
|
|
IRBT
230
DELISTED
iRobot
IRBT
| $7.01M | 0.01% |
120,000
| – | – |
|
231
Allegiant Air
ALGT
$2.57B
| $6.91M | 0.01% |
41,500
| – | – |
|
232
Adient
ADNT
$1.5B
| $6.67M | 0.01% |
+113,870
| New | +$6.01M |
|
|
JCP
233
DELISTED
J.C. Penney Company, Inc.
JCP
| $6.47M | 0.01% |
778,900
-70,900
| -8% | -$640K |
|
234
LyondellBasell Industries
LYB
$19.2B
| $6.42M | 0.01% |
74,900
-9,200
| -11% | -$772K |
|
235
Cabot Corp
CBT
$4.52B
| $6.32M | 0.01% |
125,000
| – | – |
|
236
MaxLinear
MXL
$6.8B
| $6.29M | 0.01% |
+288,700
| New | +$5.98M |
|
|
GRMN
237
Garmin
GRMN
$60B
| $6.24M | 0.01% |
128,700
-615,800
| -83% | -$30.7M |
|
|
MBII
238
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $6.08M | 0.01% |
2,843,200
-77,800
| -3% | -$162K |
|
|
DCOY
239
Decoy Therapeutics
DCOY
$2.09M
| $5.72M | 0.01% |
1
| – | – |
|
240
Crown Holdings
CCK
$13.1B
| $5.36M | 0.01% |
102,000
| – | – |
|
|
K
241
DELISTED
Kellanova
K
| $5.16M | 0.01% |
74,550
| – | – |
|
242
Range Resources
RRC
$8.95B
| $4.57M | ﹤0.01% |
133,000
-129,000
| -49% | -$4.62M |
|
|
MBLY
243
DELISTED
Mobileye N.V.
MBLY
| $4.48M | ﹤0.01% |
117,431
-21,600
| -16% | -$812K |
|
|
CRAY
244
DELISTED
Cray, Inc.
CRAY
| $4.31M | ﹤0.01% |
208,000
-133,150
| -39% | -$2.74M |
|
245
Penumbra
PEN
$12.8B
| $4.21M | ﹤0.01% |
66,000
-13,100
| -17% | -$876K |
|
|
BRCD
246
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $4.18M | ﹤0.01% |
334,747
| – | – |
|
247
Carter's
CRI
$1.47B
| $4.17M | ﹤0.01% |
48,270
| – | – |
|
|
CMA
248
DELISTED
Comerica
CMA
| $3.64M | ﹤0.01% |
53,500
| – | – |
|
|
NMBL
249
DELISTED
Nimble Storage, Inc.
NMBL
| $3.41M | ﹤0.01% |
430,400
+67,900
| +19% | +$553K |
|
|
SPLK
250
DELISTED
Splunk Inc
SPLK
| $3.05M | ﹤0.01% |
+59,700
| New | +$3.44M |
|
Similar funds
VAM
Primecap Management's Q4 2016 Portfolio in Review
As of Q4 2016, Primecap Management held 287 positions worth $102B, up 1.4% from $100B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management's Q4 2016 filing shows 14 new, 80 increased, 134 reduced and 11 closed positions. Its largest new stake was Qiagen: 17,384,319 shares worth $536M. The largest sale was QIAGEN NV, an estimated $534M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2016 buy was Qiagen: 17,384,319 shares worth $536M.
- Primecap Management added most to AstraZeneca in Q4 2016, an estimated $246M increase.
- Primecap Management's biggest Q4 2016 reduction was Charles Schwab, cutting an estimated $265M.
- Primecap Management fully exited QIAGEN NV in Q4 2016, selling an estimated $534M.
- Primecap Management's ten largest holdings make up 33% of its $102B portfolio in Q4 2016.
- Primecap Management opened 14 new positions and closed 11 in Q4 2016.
- Primecap Management's portfolio value rose 1.4% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q4 2016, filed 13 Feb 2017.